Anxiety Disorders and Solid Organ Transplantations

Sanchez C, Eymann A, De Cunto C, D’Agostino D. Quality of life in pediatric liver transplantation in a single-center in South America. Pediatric Transplantation. 2010;14(3):332–6.

Berksun Oğuz. Anksiyete ve Anksiyete Bozuklukları.Turgut Yayıncılık; 2003.

Özer Ş, Tükel R, Alkın T. Anksiyete Bozuklukları.TPD yayınları; 2006. p. 3–4.

Salman A. Sources of Suffering Fear, Greed, Guilt, Deception, Betrayal, and Revenge.1st ed. 2014. p. 5–12.

Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. Lifetime prevalence of mental disorders in U.S. adolescents: Results from the national comorbidity survey replication-adolescent supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry. 2010;49(10):980–9.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 p. 1–83.

Karakaya E, Öztop DB. Kaygı Bozukluğu Olan Çocuk ve Ergenlerde Bilişsel Davranışçı Terapi. Bilişsel Davranışçı Psikoterapi ve Araştırmalar Dergisi.2013;2(1):10–24.

İşeri E, Yüksel N. Anksiyete bozuklukları. Ruhsal Hastalıklar. Ankara; 2014. p. 700–6.

Friedberg RD, McClure JM. Clinical Practice of Cognitive Therapy with Children and Adolescents. New York: The Guilford Press; 2002.

Turna F. Yaygın Anksiyete Bozukluğu. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü, Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Washington, DC: American Psychiatric Association; 2013.

Demir T. Ayrılık Anksiyetesi Bozukluğu. In: Cetin F, Pehlivanturk B, Unal F, Uslu R, İșeri E, Turkbay T, editors. Cocuk ve Ergen Psikiyatrisi Temel Kitabı. 2008. p. 330–6.

Lavallee K. Separation Anxiety Disorder. In: Compton S, Villabo M, Kristensen H, editors. Pediatric Anxiety Disorders. 2019. p. 151–76.

Bowlby J. Ayrılma. İstanbul: Pinhan Yayıncılık; 2014.

Cartwright-Hatton S, McNicol K, Doubleday E. Anxiety in a neglected population: Prevalence of anxiety disorders in pre-adolescent children. Clinical PsychologyReview. 2006;26(7):817–33.

Copeland WE, Angold A, Shanahan L, Costello EJ. Longitudinal patterns of anxiety from childhood to adulthood: The great smoky mountains study. Journal of the American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry; 2014;53 p. 21–33.

Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry. 2003;60(8):837–44.

Göker Z, Güney E, Dinç G, Hekim Ö, Üneri ÖŞ. Çocuk ve Ergenlerde Anksiyete ile ilişkili Bozuklukların Klinik ve Demografik Özellikleri: Bir Yıllık Kesitsel Bir Örneklem. Klinik Psikiyatri Dergisi. 2015;18(1):7–14.

Layne AE, Bernat DH, Victor AM, Bernstein GA. Generalized anxiety disorder in a nonclinical sample of children: Symptom presentation and predictors of impairment. Journal of Anxiety Disorders. 2009;23(2):283–9.

Hale WW, Raaijmakers Q, Muris P, Van Hoof A, Meeus W. Developmental trajectories of adolescent anxiety disorder symptoms: A 5-year prospective community study. Journal of the American Academy of Child and Adolescent Psychiatry. 2008;47(5):556–64.

McLaughlin KA, King K. Developmental Trajectories of Anxiety and Depression in Early Adolescence. Journal of Abnormal Child Psychology. 2015;43(2):311–23.

Van Oort FVA, Greaves-Lord K, Verhulst FC, Ormel J, Huizink AC. The developmental course of anxiety symptoms during adolescence: The TRAILS study. Journal of Child Psychology and Psychiatry and Allied Disciplines. 2009;50(10):1209–17.

Chorpita BF, Moffitt CE, Gray J. Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample. Behaviour Research and Therapy. 2005;43(3):309–22.

Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum.Psychiatric Clinics of North America. Psychiatr Clin North Am; 2002;25 p. 757–74.

Bögels SM, Alden L, Beidel DC, Clark LA, Pine DS, Stein MB, et al. Social anxiety disorder: Questions and answers for the DSM-V. Depression and Anxiety. Depress Anxiety; 2010;27. p. 168–89.

Görker I, Korkmazlar Ü, Durukan M, Aydoğdu A. Çocuk ve Ergen Psikiyatri Kliniğine Başvuran Ergenlerde Belirti ve Tanı Dağılımı. Klinik Psikiyatri Dergisi.2004;7(2):103–10.

Essau CA, Conradt J, Petermann F. Frequency and comorbidity of social phobia and social fears in adolescents. Behaviour Research and Therapy. 1999;37(9):831–43.

Faravelli C, Zucchi T, Viviani B, Salmoria R, Perone A, Paionni A, et al. Epidemiology of social phobia: A clinical approach. European Psychiatry. 2000;15(1):17–24.

Grant BF, Hasin DS, Blanco C, Stinson FS, Chou SP, Goldstein RB, et al. The epidemiology of social anxiety disorder in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry. Physicians Postgraduate Press Inc.; 2005;66 p. 1351–61.

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry. Arch Gen Psychiatry; 2005;62 p. 593–602.

Davidson JRT, Hughes DL, George LK, Blazer D. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study. Psychological Medicine. 1993;23(3):709–18.

Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Archives of General Psychiatry. 2012;69(4):372–80.

Taner HA. Panik bozukluk. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü,Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

Ercan ES, Polanczyk G, Akyol Ardıc U, Yuce D, Karacetın G, Tufan AE, et al. The prevalence of childhood psychopathology in Turkey: a cross-sectional multicenter nationwide study (EPICPAT-T). Nordic Journal of Psychiatry. 2019;73(2):132–40.

Viana AG, Beidel DC, Rabian B. Selective mutism: A review and integration of the last 15 years. Clinical Psychology Review. Clin Psychol Rev; 2009;29. p. 57–67.

Higa-McMillan C, Francis S, Chorpita B. Anxiety disorders. In: Mash E, Barkley R, editors. Child Psychopathology. New York: Guilford Press; 2014. p. 345–428.

Keeton CP, Crosby Budinger M. Social Phobia and Selective Mutism. Child and Adolescent Psychiatric Clinics of North America. Child Adolesc Psychiatr Clin N Am; 2012;21. p. 621–41.

Steinhausen HC, Juzi C. Elective mutism: An analysis of 100 cases. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35(5):606–14.

Dummit ES, Klein RG, Tancer NK, Asche B, Martin J, Fairbanks JA. Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36(5):653–60.

Kristensen H. Selective mutism and comorbidity with developmental disorder/delay, anxiety disorder, and elimination disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39(2):249–56.

Bergman RL, Piacentini J, McCracken JT. Prevalence and Description of Selective Mutism in a School-Based Sample. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41(8):938–46.

Elizur Y, Perednik R. Prevalence and description of selective mutism in immigrant and native families: A controlled study. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42(12):1451–9.

Gensthaler A, Maichrowitz V, Kaess M, Ligges M, Freitag CM, Schwenck C. Selective mutism: The fraternal twin of childhood social phobia. Psychopathology. 2016;49(2):95–107.

Rapee RM. Anxiety disorders in children and adolescents: nature, development, treatment and prevention. In: Rey J, editor. IACAPAP e-Textbook of Child and Adolescent Mental Health. 2012.

Crozier M, Gillihan S, Powers M. Issues in Differential Diagnosis: Phobias and Phobic Conditions. In: Handbook of Child and Adolescent Anxiety Disorders. 2011. p. 7–22.

Ollendick TH, King NJ, Muris P. Fears and Phobias in Children: Phenomenology, Epidemiology, and Aetiology. Child and Adolescent Mental Health. 2002;7(3):98–106.

Çetinkaya M. Özgül Fobi. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü, Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

Merikangas KR. Vulnerability factors for anxiety disorders in children and adolescents.Child and Adolescent Psychiatric Clinics of North America. Elsevier; 2005;14. p. 649–79.

Hirshfeld DR, Biederman J, Brody L, Faraone S V., Rosenbaum JF. Expressed emotion toward children with behavioral inhibition: Associations with maternal anxiety disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36(7):910–7.

Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: A systematic review and meta-analysis. JAMA Pediatrics. 2017;171(11):1049–56.

Öztürk M, Karaçetin G. Çocuk ve Ergenlerde Anksiyete Bozukluklarında Farmakolojik Tedavi Yaklaşımları. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2016;2(3):47–53.

Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2009.

Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46(2):267–83.

Çöp E, Dinç GŞ, Kültür SEÇ. Kronik Hastalığı Olan Çocuk ve Ergenler. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2021;7(1):49–56.

Çöp E, Dinç GŞ, Kültür SEÇ. Kronik Hastalığı Olan Çocukların Annelerinde Baş Etme Becerilerinin Psikiyatrik Belirtiler ile İlişkisi: Bir Ön Çalışma. Türkiye Çocuk Hastalıkları Dergisi. 2016;10(3):170–6.

Özdemir Ü, Taşci S. Kronik Hastalıklarda Psikososyal Sorunlar ve Bakım. Erciyes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2013;1

Er D. Çocuk, hastalık, anne-babalar ve kardeşler. Vol. 49, Çocuk Sağlığı ve Hastalıkları Dergisi. 2006.

Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceedings. Elsevier Ltd; 2006;81. p. 1361–7.

Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus: Treatment and preventive therapy. In: Annals of the New York Academy of Sciences. Blackwell Publishing Inc. 2009. p. 41–55.

Pinho De Oliveira Ribeiro N, Rafael De Mello Schier A, Ornelas AC, Pinho De Oliveira CM, Nardi AE, Silva AC. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Comprehensive Psychiatry. 2013;54(8):1185–9.

Stuber ML, Shemesh E, Saxe GN. Posttraumatic stress responses in children with life-threatening illnesses. Child and Adolescent Psychiatric Clinics of North America. W.B. Saunders; 2003;12. p. 195–209.

Karayurt Ö, Ordin YS, Ünek T, Astarcıoğlu İ. Immunosuppressive medication adherence, therapeutic adherence, school performance, symptom experience, and depression levels in patients having undergone a liver transplant during childhood. Experimental and Clinical Transplantation. 2015;13(3):247–55.

Senses Dinc G, Cak T, Cengel Kultur E, Bilginer Y, Kul M, Topaloglu R. Psychiatric morbidity and different treatment modalities in children with chronic kidney disease. Archives de Pediatrie. 2019;26(5):263–7.

Ünay M, Önder A, Gizli Çoban Ö, Atalay A, Sürer Adanir A, Artan R, et al. Psychopathology, quality of life, and related factors in pediatric liver transplantation candidates and recipients. Pediatric Transplantation. 2020;24(1).

Thomson K, McKenna K, Bedard-Thomas K, Oliva M, Ibeziako P. Behavioral health care in solid organ transplantation in a pediatric setting. Pediatric Transplantation. 2018;22(5).

Oliver AM, Wright KD, Kakadekar A, Pharis S, Pockett C, Bradley TJ, et al. Health anxiety and associated constructs in children and adolescents with congenital heart disease: A CHAMPS cohort study. Journal of Health Psychology. 2020;25(10–11):1355–65.

Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F. Behavioural abnormalities in children with nephrotic syndrome. Nephrology Dialysis Transplantation. 2010;25(8):2537–41.

Özdemir DF, Karabucak B. Çocuk ve Ergende Yoğun Bakım ve Palyatif Bakımda Konsültasyon Liyezon Psikiyatrisi. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2016;2(2):86–94.

Meyer EC, DeMaso DR, Koocher GP. Mental health consultation in the pediatric intensive care unit. Professional Psychology: Research and Practice. 1996;27(2):130–6.

Torun YT, Güney E. Çocuk ve Ergende Organ Transplantasyonunda Konsültasyon Liyezon Psikiyatrisi. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2016;2(2):81–5.

Sağduyu A, Özel S. Böbrek nakli adaylarında ruhsal sorunlar ve yetiyitimi. Türk Psikiyatri Dergisi. 2000;11(2):103–12.

Yatkın I, Çalışkan M. Renal transplantasyon hastalarında ve vericilerde transplantasyon öncesi ve Sonrasında depresyon, anksiyete, yaşam Kalitesi ve sosyal destek. İstanbul; 2009.

Cürcani M. Böbrek Transplantasyonu Yapılmış Hastalara Verilen Eğitimin Hastaların Yaşam Kalitesi, Tedaviye Uyumları Ve Yasadıkları Ruhsal Sorunlar Üzerine Etkisi. Erzurum; 2008.

Çelik A, Özbey H. Çocuklarda ameliyatların psikosoyal etkileri. In: Ben Hasta Değilim. İstanbul: Nobel Tıp Kitabevi; 1999. p. 403–6.

Simons L, Ingerski LM, Janicke DM. Social support, coping, and psychological distress in mothers and fathers of pediatric transplant candidates: A pilot study. Pediatric Transplantation. 2007;11(7):781–7.

Avşar U, Avşar UZ, Cansever Z, Yucel A, Cankaya E, Certez H, et al. Caregiver Burden, Anxiety, Depression, and Sleep Quality Differences in Caregivers of Hemodialysis Patients Compared with Renal Transplant Patients. In: Transplantation Proceedings. Elsevier USA; 2015. p. 1388–91.

Weil CM, Rodgers S, Rubovits S. School re-entry of the pediatric heart transplant recipient. Pediatric Transplantation. 2006;10(8):928–33.

Samsel C, Tapsak S, Thomson K, McKenna K, McGregor K, Forbes P, et al. Psychotropic medication use trends in a large pediatric and young adult solid organ transplant population. Pediatric Transplantation. 2019;23(3).

Biour M, Salem B, Chazouillères O, Grangé J-D, Serfaty L, Poupon R. Hépatotoxicité des médicaments 14 e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol. 2004;28.

Ay MG. Tıbbi Durumlarda Psikofarmakolojik Yaklaşımlar. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü, Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

Taylor DPC. The Maudsley Prescribing Guidelines. 10th ed. London: CRC Press; 2009.

Atmaca M. Acute severe hepatotoxicity associated with clomipramine. Klinik Psikofarmakoloji Bulteni. 2011;21(2):154–5.

Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: A review for clinicians. Vol. 171, American Journal of Psychiatry. American Psychiatric Association; 2014. p. 404–15.

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clinical Pharmacology and Therapeutics. 2011;89(6):806–15.

Taylor DM, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry. John Wiley & Sons; 2015.

Telles-Correia D, Barbosa A, Cortez-Pinto H, Campos C, Rocha NBF, Machado S. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;8(1):26.

Taylor D, Barnes T, Young A. The Maudsley Prescribing Guidelines in Psychiatry. John Wiley & Sons; 2018.

Boyer WBC. The safety profile of paroxetine. The Journal of clinical psychiatry. 1992;53:61–6.

Andrade RJ, Lucena MI, Alcantara R, Fraile JM. Bentazepam-associated chronic liver disease. The Lancet. Lancet; 1994;343. p. 860.

Fang MH, Ginsberg AL, Dobbins WO. Cholestatic jaundice associated with flurazepam hydrochloride. Annals of Internal Medicine. 1978;89(3):363–4.

Levy NB. Psychopharmacology in patients with renal failure. International Journal of Psychiatry in Medicine. 1990;20(4):325–34.

Semerci B, Ozturk M, Turkbay T. Ergen Psikofarmakolojisi. İstanbul: Renk Matbaası Basım; 2015. 227–243 p.

Güney SA, Şahbudak B. Çocuk ve Ergen Psikiyatrisinde Antidepresanlar ve Anksiyolitikler. Turkiye Klinikleri Child Psychiatry - Special Topics. 2017;3(1):8–15.

Stahl S. Stahl’s essential psychopharmacology: Prescriber’s guide: Cambridge University Press; 2014.

Mcintyre RS, Baghdady NT, Banik S, Swartz SA. The use of psychotropic drugs in patients with impaired renal function. Primary Psychiatry. 2008;15(1):73–88.

Gaziano J. Global burden of cardiovascular disease. In: Zipes D, Libby P, Bonow RmbE, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 2005.

Glassman AH, Preud’homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. The Journal of Clinical Psychiatry. 1993;54(2):16–22.

Fernandez F. Depression and its treatment in cardiac patients. Texas Hearl Institute journal. 1993;20(3):188–97.

Cochran KA, Cavallari LH, Shapiro NL, Bishop JR. Bleeding incidence with concomitant use of antidepressants and warfarin. Therapeutic Drug Monitoring. 2011;33(4):433–8.

Bruni O, Alonso-Alconada D, Besag F, Biran V, Braam W, Cortese S, et al. Current role of melatonin in pediatric neurology: Clinical recommendations. European Journal of Paediatric Neurology. W.B. Saunders Ltd; 2015;19. p. 122–33.

British National Formulary for Children. London: BMA/RPSGB; 2013.

Cohen LM, Tessier EG, Germain MJ, Levy NB. Update on Psychotropic Medication Use in Renal Disease. Psychosomatics. 2004;45(1):34–48.

Stoddard FJ, Usher CT, Abrams AN. Psychopharmacology in Pediatric Critical Care. Child and Adolescent Psychiatric Clinics of North America. Elsevier; 2006;15. p. 611–55.

Türkbay T. Konsültasyon-liyezon psikiyatrisinde psikofarmakoloji. In: Tüzün D, Hergüner S, editors. Çocuk Hastalıklarında Biyopsikososyal Biyopsikososyal Yaklaşım. 1st ed. 2007. p. 421–45.

Sanchez C, Eymann A, De Cunto C, D’Agostino D. Quality of life in pediatric liver transplantation in a single-center in South America. Pediatric Transplantation. 2010;14(3):332–6.

Berksun Oğuz. Anksiyete ve Anksiyete Bozuklukları.Turgut Yayıncılık; 2003.

Özer Ş, Tükel R, Alkın T. Anksiyete Bozuklukları.TPD yayınları; 2006. p. 3–4.

Salman A. Sources of Suffering Fear, Greed, Guilt, Deception, Betrayal, and Revenge.1st ed. 2014. p. 5–12.

Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. Lifetime prevalence of mental disorders in U.S. adolescents: Results from the national comorbidity survey replication-adolescent supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry. 2010;49(10):980–9.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 p. 1–83.

Karakaya E, Öztop DB. Kaygı Bozukluğu Olan Çocuk ve Ergenlerde Bilişsel Davranışçı Terapi. Bilişsel Davranışçı Psikoterapi ve Araştırmalar Dergisi.2013;2(1):10–24.

İşeri E, Yüksel N. Anksiyete bozuklukları. Ruhsal Hastalıklar. Ankara; 2014. p. 700–6.

Friedberg RD, McClure JM. Clinical Practice of Cognitive Therapy with Children and Adolescents. New York: The Guilford Press; 2002.

Turna F. Yaygın Anksiyete Bozukluğu. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü, Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Washington, DC: American Psychiatric Association; 2013.

Demir T. Ayrılık Anksiyetesi Bozukluğu. In: Cetin F, Pehlivanturk B, Unal F, Uslu R, İșeri E, Turkbay T, editors. Cocuk ve Ergen Psikiyatrisi Temel Kitabı. 2008. p. 330–6.

Lavallee K. Separation Anxiety Disorder. In: Compton S, Villabo M, Kristensen H, editors. Pediatric Anxiety Disorders. 2019. p. 151–76.

Bowlby J. Ayrılma. İstanbul: Pinhan Yayıncılık; 2014.

Cartwright-Hatton S, McNicol K, Doubleday E. Anxiety in a neglected population: Prevalence of anxiety disorders in pre-adolescent children. Clinical PsychologyReview. 2006;26(7):817–33.

Copeland WE, Angold A, Shanahan L, Costello EJ. Longitudinal patterns of anxiety from childhood to adulthood: The great smoky mountains study. Journal of the American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry; 2014;53 p. 21–33.

Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry. 2003;60(8):837–44.

Göker Z, Güney E, Dinç G, Hekim Ö, Üneri ÖŞ. Çocuk ve Ergenlerde Anksiyete ile ilişkili Bozuklukların Klinik ve Demografik Özellikleri: Bir Yıllık Kesitsel Bir Örneklem. Klinik Psikiyatri Dergisi. 2015;18(1):7–14.

Layne AE, Bernat DH, Victor AM, Bernstein GA. Generalized anxiety disorder in a nonclinical sample of children: Symptom presentation and predictors of impairment. Journal of Anxiety Disorders. 2009;23(2):283–9.

Hale WW, Raaijmakers Q, Muris P, Van Hoof A, Meeus W. Developmental trajectories of adolescent anxiety disorder symptoms: A 5-year prospective community study. Journal of the American Academy of Child and Adolescent Psychiatry. 2008;47(5):556–64.

McLaughlin KA, King K. Developmental Trajectories of Anxiety and Depression in Early Adolescence. Journal of Abnormal Child Psychology. 2015;43(2):311–23.

Van Oort FVA, Greaves-Lord K, Verhulst FC, Ormel J, Huizink AC. The developmental course of anxiety symptoms during adolescence: The TRAILS study. Journal of Child Psychology and Psychiatry and Allied Disciplines. 2009;50(10):1209–17.

Chorpita BF, Moffitt CE, Gray J. Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample. Behaviour Research and Therapy. 2005;43(3):309–22.

Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum.Psychiatric Clinics of North America. Psychiatr Clin North Am; 2002;25 p. 757–74.

Bögels SM, Alden L, Beidel DC, Clark LA, Pine DS, Stein MB, et al. Social anxiety disorder: Questions and answers for the DSM-V. Depression and Anxiety. Depress Anxiety; 2010;27. p. 168–89.

Görker I, Korkmazlar Ü, Durukan M, Aydoğdu A. Çocuk ve Ergen Psikiyatri Kliniğine Başvuran Ergenlerde Belirti ve Tanı Dağılımı. Klinik Psikiyatri Dergisi.2004;7(2):103–10.

Essau CA, Conradt J, Petermann F. Frequency and comorbidity of social phobia and social fears in adolescents. Behaviour Research and Therapy. 1999;37(9):831–43.

Faravelli C, Zucchi T, Viviani B, Salmoria R, Perone A, Paionni A, et al. Epidemiology of social phobia: A clinical approach. European Psychiatry. 2000;15(1):17–24.

Grant BF, Hasin DS, Blanco C, Stinson FS, Chou SP, Goldstein RB, et al. The epidemiology of social anxiety disorder in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry. Physicians Postgraduate Press Inc.; 2005;66 p. 1351–61.

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry. Arch Gen Psychiatry; 2005;62 p. 593–602.

Davidson JRT, Hughes DL, George LK, Blazer D. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study. Psychological Medicine. 1993;23(3):709–18.

Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Archives of General Psychiatry. 2012;69(4):372–80.

Taner HA. Panik bozukluk. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü,Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

Ercan ES, Polanczyk G, Akyol Ardıc U, Yuce D, Karacetın G, Tufan AE, et al. The prevalence of childhood psychopathology in Turkey: a cross-sectional multicenter nationwide study (EPICPAT-T). Nordic Journal of Psychiatry. 2019;73(2):132–40.

Viana AG, Beidel DC, Rabian B. Selective mutism: A review and integration of the last 15 years. Clinical Psychology Review. Clin Psychol Rev; 2009;29. p. 57–67.

Higa-McMillan C, Francis S, Chorpita B. Anxiety disorders. In: Mash E, Barkley R, editors. Child Psychopathology. New York: Guilford Press; 2014. p. 345–428.

Keeton CP, Crosby Budinger M. Social Phobia and Selective Mutism. Child and Adolescent Psychiatric Clinics of North America. Child Adolesc Psychiatr Clin N Am; 2012;21. p. 621–41.

Steinhausen HC, Juzi C. Elective mutism: An analysis of 100 cases. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35(5):606–14.

Dummit ES, Klein RG, Tancer NK, Asche B, Martin J, Fairbanks JA. Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36(5):653–60.

Kristensen H. Selective mutism and comorbidity with developmental disorder/delay, anxiety disorder, and elimination disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39(2):249–56.

Bergman RL, Piacentini J, McCracken JT. Prevalence and Description of Selective Mutism in a School-Based Sample. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41(8):938–46.

Elizur Y, Perednik R. Prevalence and description of selective mutism in immigrant and native families: A controlled study. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42(12):1451–9.

Gensthaler A, Maichrowitz V, Kaess M, Ligges M, Freitag CM, Schwenck C. Selective mutism: The fraternal twin of childhood social phobia. Psychopathology. 2016;49(2):95–107.

Rapee RM. Anxiety disorders in children and adolescents: nature, development, treatment and prevention. In: Rey J, editor. IACAPAP e-Textbook of Child and Adolescent Mental Health. 2012.

Crozier M, Gillihan S, Powers M. Issues in Differential Diagnosis: Phobias and Phobic Conditions. In: Handbook of Child and Adolescent Anxiety Disorders. 2011. p. 7–22.

Ollendick TH, King NJ, Muris P. Fears and Phobias in Children: Phenomenology, Epidemiology, and Aetiology. Child and Adolescent Mental Health. 2002;7(3):98–106.

Çetinkaya M. Özgül Fobi. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü, Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

Merikangas KR. Vulnerability factors for anxiety disorders in children and adolescents.Child and Adolescent Psychiatric Clinics of North America. Elsevier; 2005;14. p. 649–79.

Hirshfeld DR, Biederman J, Brody L, Faraone S V., Rosenbaum JF. Expressed emotion toward children with behavioral inhibition: Associations with maternal anxiety disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36(7):910–7.

Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: A systematic review and meta-analysis. JAMA Pediatrics. 2017;171(11):1049–56.

Öztürk M, Karaçetin G. Çocuk ve Ergenlerde Anksiyete Bozukluklarında Farmakolojik Tedavi Yaklaşımları. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2016;2(3):47–53.

Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2009.

Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46(2):267–83.

Çöp E, Dinç GŞ, Kültür SEÇ. Kronik Hastalığı Olan Çocuk ve Ergenler. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2021;7(1):49–56.

Çöp E, Dinç GŞ, Kültür SEÇ. Kronik Hastalığı Olan Çocukların Annelerinde Baş Etme Becerilerinin Psikiyatrik Belirtiler ile İlişkisi: Bir Ön Çalışma. Türkiye Çocuk Hastalıkları Dergisi. 2016;10(3):170–6.

Özdemir Ü, Taşci S. Kronik Hastalıklarda Psikososyal Sorunlar ve Bakım. Erciyes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2013;1

Er D. Çocuk, hastalık, anne-babalar ve kardeşler. Vol. 49, Çocuk Sağlığı ve Hastalıkları Dergisi. 2006.

Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceedings. Elsevier Ltd; 2006;81. p. 1361–7.

Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus: Treatment and preventive therapy. In: Annals of the New York Academy of Sciences. Blackwell Publishing Inc. 2009. p. 41–55.

Pinho De Oliveira Ribeiro N, Rafael De Mello Schier A, Ornelas AC, Pinho De Oliveira CM, Nardi AE, Silva AC. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Comprehensive Psychiatry. 2013;54(8):1185–9.

Stuber ML, Shemesh E, Saxe GN. Posttraumatic stress responses in children with life-threatening illnesses. Child and Adolescent Psychiatric Clinics of North America. W.B. Saunders; 2003;12. p. 195–209.

Karayurt Ö, Ordin YS, Ünek T, Astarcıoğlu İ. Immunosuppressive medication adherence, therapeutic adherence, school performance, symptom experience, and depression levels in patients having undergone a liver transplant during childhood. Experimental and Clinical Transplantation. 2015;13(3):247–55.

Senses Dinc G, Cak T, Cengel Kultur E, Bilginer Y, Kul M, Topaloglu R. Psychiatric morbidity and different treatment modalities in children with chronic kidney disease. Archives de Pediatrie. 2019;26(5):263–7.

Ünay M, Önder A, Gizli Çoban Ö, Atalay A, Sürer Adanir A, Artan R, et al. Psychopathology, quality of life, and related factors in pediatric liver transplantation candidates and recipients. Pediatric Transplantation. 2020;24(1).

Thomson K, McKenna K, Bedard-Thomas K, Oliva M, Ibeziako P. Behavioral health care in solid organ transplantation in a pediatric setting. Pediatric Transplantation. 2018;22(5).

Oliver AM, Wright KD, Kakadekar A, Pharis S, Pockett C, Bradley TJ, et al. Health anxiety and associated constructs in children and adolescents with congenital heart disease: A CHAMPS cohort study. Journal of Health Psychology. 2020;25(10–11):1355–65.

Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F. Behavioural abnormalities in children with nephrotic syndrome. Nephrology Dialysis Transplantation. 2010;25(8):2537–41.

Özdemir DF, Karabucak B. Çocuk ve Ergende Yoğun Bakım ve Palyatif Bakımda Konsültasyon Liyezon Psikiyatrisi. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2016;2(2):86–94.

Meyer EC, DeMaso DR, Koocher GP. Mental health consultation in the pediatric intensive care unit. Professional Psychology: Research and Practice. 1996;27(2):130–6.

Torun YT, Güney E. Çocuk ve Ergende Organ Transplantasyonunda Konsültasyon Liyezon Psikiyatrisi. Türkiye Klinikleri Çocuk Psikiyatrisi - Özel Konular. 2016;2(2):81–5.

Sağduyu A, Özel S. Böbrek nakli adaylarında ruhsal sorunlar ve yetiyitimi. Türk Psikiyatri Dergisi. 2000;11(2):103–12.

Yatkın I, Çalışkan M. Renal transplantasyon hastalarında ve vericilerde transplantasyon öncesi ve Sonrasında depresyon, anksiyete, yaşam Kalitesi ve sosyal destek. İstanbul; 2009.

Cürcani M. Böbrek Transplantasyonu Yapılmış Hastalara Verilen Eğitimin Hastaların Yaşam Kalitesi, Tedaviye Uyumları Ve Yasadıkları Ruhsal Sorunlar Üzerine Etkisi. Erzurum; 2008.

Çelik A, Özbey H. Çocuklarda ameliyatların psikosoyal etkileri. In: Ben Hasta Değilim. İstanbul: Nobel Tıp Kitabevi; 1999. p. 403–6.

Simons L, Ingerski LM, Janicke DM. Social support, coping, and psychological distress in mothers and fathers of pediatric transplant candidates: A pilot study. Pediatric Transplantation. 2007;11(7):781–7.

Avşar U, Avşar UZ, Cansever Z, Yucel A, Cankaya E, Certez H, et al. Caregiver Burden, Anxiety, Depression, and Sleep Quality Differences in Caregivers of Hemodialysis Patients Compared with Renal Transplant Patients. In: Transplantation Proceedings. Elsevier USA; 2015. p. 1388–91.

Weil CM, Rodgers S, Rubovits S. School re-entry of the pediatric heart transplant recipient. Pediatric Transplantation. 2006;10(8):928–33.

Samsel C, Tapsak S, Thomson K, McKenna K, McGregor K, Forbes P, et al. Psychotropic medication use trends in a large pediatric and young adult solid organ transplant population. Pediatric Transplantation. 2019;23(3).

Biour M, Salem B, Chazouillères O, Grangé J-D, Serfaty L, Poupon R. Hépatotoxicité des médicaments 14 e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol. 2004;28.

Ay MG. Tıbbi Durumlarda Psikofarmakolojik Yaklaşımlar. In: Ercan ES, Bilaç Ö, Yazıcı İP, Kütük MÖ, Işık Ü, Kılıçoğlu AG, et al., editors. Çocuk ve Ergen Psikiyatrisi Güncel Yaklaşımlar ve Temel Kavramlar. Akademisyen Kitabevi; 2020.

Taylor DPC. The Maudsley Prescribing Guidelines. 10th ed. London: CRC Press; 2009.

Atmaca M. Acute severe hepatotoxicity associated with clomipramine. Klinik Psikofarmakoloji Bulteni. 2011;21(2):154–5.

Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: A review for clinicians. Vol. 171, American Journal of Psychiatry. American Psychiatric Association; 2014. p. 404–15.

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clinical Pharmacology and Therapeutics. 2011;89(6):806–15.

Taylor DM, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry. John Wiley & Sons; 2015.

Telles-Correia D, Barbosa A, Cortez-Pinto H, Campos C, Rocha NBF, Machado S. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;8(1):26.

Taylor D, Barnes T, Young A. The Maudsley Prescribing Guidelines in Psychiatry. John Wiley & Sons; 2018.

Boyer WBC. The safety profile of paroxetine. The Journal of clinical psychiatry. 1992;53:61–6.

Andrade RJ, Lucena MI, Alcantara R, Fraile JM. Bentazepam-associated chronic liver disease. The Lancet. Lancet; 1994;343. p. 860.

Fang MH, Ginsberg AL, Dobbins WO. Cholestatic jaundice associated with flurazepam hydrochloride. Annals of Internal Medicine. 1978;89(3):363–4.

Levy NB. Psychopharmacology in patients with renal failure. International Journal of Psychiatry in Medicine. 1990;20(4):325–34.

Semerci B, Ozturk M, Turkbay T. Ergen Psikofarmakolojisi. İstanbul: Renk Matbaası Basım; 2015. 227–243 p.

Güney SA, Şahbudak B. Çocuk ve Ergen Psikiyatrisinde Antidepresanlar ve Anksiyolitikler. Turkiye Klinikleri Child Psychiatry - Special Topics. 2017;3(1):8–15.

Stahl S. Stahl’s essential psychopharmacology: Prescriber’s guide: Cambridge University Press; 2014.

Mcintyre RS, Baghdady NT, Banik S, Swartz SA. The use of psychotropic drugs in patients with impaired renal function. Primary Psychiatry. 2008;15(1):73–88.

Gaziano J. Global burden of cardiovascular disease. In: Zipes D, Libby P, Bonow RmbE, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 2005.

Glassman AH, Preud’homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. The Journal of Clinical Psychiatry. 1993;54(2):16–22.

Fernandez F. Depression and its treatment in cardiac patients. Texas Hearl Institute journal. 1993;20(3):188–97.

Cochran KA, Cavallari LH, Shapiro NL, Bishop JR. Bleeding incidence with concomitant use of antidepressants and warfarin. Therapeutic Drug Monitoring. 2011;33(4):433–8.

Bruni O, Alonso-Alconada D, Besag F, Biran V, Braam W, Cortese S, et al. Current role of melatonin in pediatric neurology: Clinical recommendations. European Journal of Paediatric Neurology. W.B. Saunders Ltd; 2015;19. p. 122–33.

British National Formulary for Children. London: BMA/RPSGB; 2013.

Cohen LM, Tessier EG, Germain MJ, Levy NB. Update on Psychotropic Medication Use in Renal Disease. Psychosomatics. 2004;45(1):34–48.

Stoddard FJ, Usher CT, Abrams AN. Psychopharmacology in Pediatric Critical Care. Child and Adolescent Psychiatric Clinics of North America. Elsevier; 2006;15. p. 611–55.

Türkbay T. Konsültasyon-liyezon psikiyatrisinde psikofarmakoloji. In: Tüzün D, Hergüner S, editors. Çocuk Hastalıklarında Biyopsikososyal Biyopsikososyal Yaklaşım. 1st ed. 2007. p. 421–45.